For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.
He first came into contact with the stock market and shares during his banking apprenticeship. After completing this in 2000, he gained his first journalistic experience in the editorial department of a financial portal. During his subsequent studies in business administration, he also worked in the area of investor relations.
Since then, he has remained true to the capital markets and is excited to report on every newly discovered interesting story - as well as on long-standing success stories.
Commented by Fabian Lorenz
Commented by Fabian Lorenz on September 28th, 2022 | 11:22 CEST
Time for bargain hunters? Plug Power, Varta and Pathfinder Ventures
Growth stocks are currently under particular pressure. But this can also create opportunities for bargain hunters. Perhaps in the case of Varta? The share has crashed sharply after a profit warning. Now, the first analyst has upgraded the share from "sell" to "buy". But even his reasoning does not sound like a new growth story. Plug Power also tends to live on the hope of growth. While the new production facility is technically a milestone, it needs more. In contrast, things are going well at Pathfinder Ventures. The still unknown tourism company is profiting from the camping boom in North America, and its valuation is anything but expensive.
Read
Commented by Fabian Lorenz on September 23rd, 2022 | 11:17 CEST
Nel, Steinhoff, Viva Gold: What is going on?
Is the rebound coming for the Nel share, or are all the dams breaking? At the moment, this is the situation with the popular hydrogen specialist. After the quarterly figures, Credit Suisse, among others, lowered their thumbs and the share is also clearly battered on the chart. The latter also applies to Viva Gold. Operationally, things are going well for the Canadians. Can a stabilizing gold price turn investors' attention to the low valuation? Investors have been debating for years whether Steinhoff is favorably valued or not. Recently, the share price jumped significantly. What is going on?
Read
Commented by Fabian Lorenz on September 21st, 2022 | 12:33 CEST
BYD, Varta, Globex Mining: Shares with diversification
Diversification reduces risks. This applies not only to investments but also to companies. BYD, for example, sells not only cars but also batteries, commercial vehicles and more. The focus is currently clearly on the car division, but the Chinese group is also stepping on the gas in its foreign expansion in other areas. With more than 200 holdings in the commodities sector, Globex Mining is also broadly diversified, and its cash holdings alone now account for a good half of its market capitalization. In addition, there is positive news from the projects. Varta is trying to diversify with its entry into battery production. However, the Company is not making any progress in this. Perhaps there will be news at an investor conference next week.
Read
Commented by Fabian Lorenz on September 15th, 2022 | 11:23 CEST
Nordex, Rheinmetall, Barsele Minerals: Turnaround potential!
These three stocks have turnaround potential. Admittedly, investing is not easy in the current environment with inflation, rising interest rates and war in Ukraine. But challenging times offer great opportunities. Take Rheinmetall, for example: The stock has corrected by over 30%, yet the prospects are good and analysts also see a price potential of over 70%. Nordex has many problems of its own making, but here too, the industry environment is right, thanks to global investment packages for renewable energy. At Barsele Minerals, the gold price is a burden, but in the meantime, the market capitalization is well below the asset's value, and the recent capital increase was significantly oversubscribed.
Read
Commented by Fabian Lorenz on September 14th, 2022 | 13:05 CEST
Analysts are bullish on BYD, less bullish on Varta and news from Infinity Stone Ventures
In terms of sales figures, BYD has already overtaken industry star Tesla. But the share could not benefit from this due to the partial sales of major shareholder Berkshire Hathaway. After the price slide, it now seems to be regaining its footing. Analysts are bullish and see great opportunities for the Chinese e-car maker in foreign expansion, among other things. Experts see few opportunities at Varta at the moment, and the chart is battered. Most recently, an analyst reduced the price target to EUR 65. The newsflow currently offers little hope. Infinity Stone Ventures is an entirely different story. The specialist for critical raw materials in Canada benefits from the political environment and is expanding its lithium areas. More news can be expected in the fall.
Read
Commented by Fabian Lorenz on September 9th, 2022 | 10:53 CEST
300% chance with MorphoSys share? News from BioNTech and Defence Therapeutics
Analysts see a 300% price potential for MorphoSys. However, the latest quarterly figures did not give cause for euphoria. And not all analysts are so positive. On the other hand, BioNTech is currently doing well. The Mainz-based Company has received approval for its Omicron vaccine in the UK. However, the sustainable share price is increasingly determined by the pipeline. There is important news concerning the pipeline at Defence Therapeutics. In preclinical studies for the development of a novel cellular vaccine to fight cancer, the survival rate was 100%. The Canadians' unconventional approach could revolutionize modern medicine. More on the three biotech stocks here.
Read
Commented by Fabian Lorenz on September 7th, 2022 | 13:29 CEST
Commodity shares K+S, Barrick Gold, Manuka Resources: Gold price at 50,000?
The price of a troy ounce of gold rises to USD 50,000. This scenario is probably the dream of every gold bull and also for companies like Barrick Gold and Manuka Resources. John Butler has proclaimed this price target. The Head of Treasury of TallyMoney and author of The Golden Revolution has described the scenario to reach this price target in an interview. The prerequisite is that the world moves to a gold standard monetary system. And this is not as unlikely as one might think because the economic dominance of the USA has been declining for years, and the BRICS countries are reportedly already working on a reserve currency. K+S is also currently under pressure. Price targets of analysts differ significantly.
Read
Commented by Fabian Lorenz on September 1st, 2022 | 12:29 CEST
BYD after Buffett shock - Better to bet on JinkoSolar and Meta Materials?
So, now it is done: Star investor Warren Buffett has sold shares in the Tesla hunter, BYD. Although it is only a small part of the investment, the BYD share went down significantly. Because now, the door is open to speculation about what will happen to the legal shares - Buffett's Berkshire Hathaway still holds almost 19% of the Chinese carmaker. The convincing quarterly figures have thus receded into the background. JinkoSolar has presented mixed figures. The Company is benefiting from the skyrocketing electricity and gas prices. After all, they are driving demand for solar systems, but analysts are divided. Meta Materials' innovative functional materials are also expected to revolutionize renewable energy production in the future. For further development, the patent octopus has now strengthened itself with a veteran of the chip industry.
Read
Commented by Fabian Lorenz on August 31st, 2022 | 11:46 CEST
Poison pill slows down Nel share - will BioNTech and Almonty Industries soon take off?
The Nel ASA share is currently not for the faint-hearted. The stock is caught between hydrogen euphoria and a downward chart trend. Yet the news from the Company and the industry - such as the deal between Plug Power and Amazon - has been positive overall recently. But there is a poison pill. In contrast, the coming week could be exciting for BioNTech shareholders. In Germany, deliveries of the Corona vaccine, which has been adapted to virus variants, is scheduled to start. This could also give the shares of the German biotech flagship a new lease of life. The Almonty share could also soon break the knot. The discussion about reducing dependence on China for raw materials is picking up speed. Consistent with this, Almonty reports progress in the development of the tungsten mine in South Korea.
Read
Commented by Fabian Lorenz on August 18th, 2022 | 10:21 CEST
Sell Nel ASA? Buy HelloFresh and Aspermont?
Despite individual setbacks, the mood on the stock market is currently good and the summer rally is underway. Alongside shares from the technology sector, hydrogen stocks such as Plug Power and Nel ASA are currently among the high flyers. However, JPMorgan is interfering. The analysts rate the hydrogen specialist as "Underweight" and thus advise selling. They believe the share price could drop by a significant double-digit percentage. In contrast, two analysts have commented positively on HelloFresh. Berenberg even sees a doubling potential. There are also praising words for Aspermont. The debt-free Company is growing, the new fintech platform is exciting, and the valuation is very low compared to the peer group.
Read